93 related articles for article (PubMed ID: 806881)
1. Measles immunization status in 1972 among first- and second-grade school children in Danbury, Connecticut.
Lepow ML; Steele FM; Ross MR; Randolph MF
Pediatrics; 1975 Mar; 55(3):348-53. PubMed ID: 806881
[TBL] [Abstract][Full Text] [Related]
2. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
3. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
Linnemann CC; Dine MS; Roselle GA; Askey PA
Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
[TBL] [Abstract][Full Text] [Related]
4. Age of measles immunization in tropics.
Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
[TBL] [Abstract][Full Text] [Related]
5. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
[TBL] [Abstract][Full Text] [Related]
7. Ineffectiveness of historical data in predicting measles susceptibility.
Scott RM; Butler AB; Schydlower M; Rawlings P
Pediatrics; 1984 Jun; 73(6):777-80. PubMed ID: 6728580
[TBL] [Abstract][Full Text] [Related]
8. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
[TBL] [Abstract][Full Text] [Related]
9. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
[TBL] [Abstract][Full Text] [Related]
10. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
[TBL] [Abstract][Full Text] [Related]
11. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
Unalan H; Ustaçelebi S
Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
[TBL] [Abstract][Full Text] [Related]
14. [The state of measles immunity and the success quota of measles vaccination in Basle nursery and elementary school pupils].
Just M; Baechlin A; Berger R; Bürgin-Wolff A
Schweiz Med Wochenschr; 1980 Apr; 110(14):528-30. PubMed ID: 7375902
[TBL] [Abstract][Full Text] [Related]
15. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
[TBL] [Abstract][Full Text] [Related]
16. Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine.
Ajjan N; Fayet MT; Biron G; Charbonnier C; Nicolas A; Triau R; Roumiantzeff M
Dev Biol Stand; 1978; 41():209-16. PubMed ID: 111980
[TBL] [Abstract][Full Text] [Related]
17. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
[TBL] [Abstract][Full Text] [Related]
18. Measles antibody in the children in Ubon Ratchathani province.
Saipan P; Jiwapaisarnpong T; Pattanadilok S; Loyha Y; Janggajit T
J Med Assoc Thai; 2001 Apr; 84(4):500-6. PubMed ID: 11460960
[TBL] [Abstract][Full Text] [Related]
19. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
[TBL] [Abstract][Full Text] [Related]
20. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
